CI
BCRX icon

CX Institutional’s BioCryst Pharmaceuticals BCRX Stock Holding History

CX Institutional’s Portfolio BCRX Stock Details BCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,760
Closed -$19K – 515
2022
Q2 		$19K Buy
+1,760
New +$19K ﹤0.01% 849